CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield
The Hindu
“The aim of the study is to assess whether a person can be given two different vaccine shots — one each of Covishield and Covaxin”
An expert panel of India’s central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a clinical trial of mixing of two COVID-19 vaccines — Covaxin and Covishield — official sources said. The panel also recommended giving approval to Bharat Biotech for carrying out a study on interchangeability of its Covaxin and the under-trial adenoviral intranasal vaccine candidate BBV154, but asked the Hyderabad-based firm to remove the word “interchangeability” from the study title and submit a revised protocol for approval. “The SEC (subject expert committee) after detailed deliberations recommended granting permission to CMC, Vellore for conducting the phase-4 clinical trial covering 300 healthy volunteers for mixing of COVID-19 vaccines Covaxin and Covishield,” a source said.More Related News
India train in 'Big Apple': Getting used to cooler temperatures, playing white-ball games in morning
Virat Kohli takes break, Indian cricket team prepares for T20 World Cup in New York with morning training sessions.